The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial
Open accessAbstract
Purpose: To improve the poor prognosis of patients with primary disseminated multifocal Ewing sarcomas (PDMES) with a dose-intense treatment concept. Patients and Methods: From 1999 to 2005, 281 patients with PDMES were enrolled onto the Euro-EWING 99 R3 study. Median age was 16.2 years (range, 0.4 to 49 years). Recommended treatment consisted of six cycles of vincristine, ifosfamide, doxorubicin, and etoposide (VIDE), one cycle of vincristine, dactinomycin, and ifosfamide (VAI), local treatment (surgery and/or radiotherapy), and high-dose busulfan-melphalan followed by autologous stem-cell transplantation (HDT/SCT). Results: After a median follow-up of 3.8 years, event-free survival (EFS) and overall survival (OS) at 3 years for all 281 patients were 27% ± 3% and 34% ± 4% respectively. Six VIDE cycles were completed by 250 patients (89%); 169 patients (60%) received HDT/SCT. The estimated 3-year EFS from the start of HDT/SCT was 45% for 46 children younger than 14 years. Cox regression analyses demonstrated increased risk at diagnosis for patients older than 14 years (hazard ratio [HR] = 1.6), a primary tumor volume more than 200 mL (HR = 1.8), more than one bone metastatic site (HR = 2.0), bone marrow metastases (HR = 1.6), and additional lung metastases (HR = 1.5). An up-front risk score based on these HR factors identified three groups with EFS rates of 50% for score ≤ 3 (82 patients), 25% for score more than 3 to less than 5 (102 patients), and 10% for score ≥ 5 (70 patients; P < .0001). Conclusion: PDMES patients may survive with intensive multimodal therapy. Age, tumor volume, and extent of metastatic spread are relevant risk factors. A score based on these factors may facilitate risk-adapted treatment approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Goycoolea, A. (1997) · Cited by 3,615
Ford, R., & Eisenberg, S. (1990) · Nursing Clinics of North America · doi:10.1016/s0029-6465(22)02934-6 · Cited by 2,720
Presentation of multivariate data for clinical use: The Framingham Study risk score functions
Sullivan, L. M., Massaro, J. M., & D'Agostino, R. B. (2004) · Statistics in Medicine · doi:10.1002/sim.1742 · Cited by 1,753
Grier, H. E., Krailo, M. D., Tarbell, N. J., Link, M. P., Fryer, C. J. H., Pritchard, D. J., Gebhardt, M. C., Dickman, P. S., Perlman, E. J., Meyers, P. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020890 · Cited by 1,328
Cotterill, S. J., Ahrens, S., Paulussen, M., Jürgens, H. F., Voûte, P. A., Gadner, H., & Craft, A. W. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3108 · Cited by 1,040
Self-citationSurvival Analysis: A Practical Approach.
Smith, P. J., Parmar, M. K. B., & David, M. (1996) · Journal of the American Statistical Association · doi:10.2307/2291609 · Cited by 730
Jürgens, H., Exner, U., Gadner, H., Harms, D., Michaelis, J., Sauer, R., Treuner, J., Voûte, T., Winkelmann, W., Winkler, K., et al. (1988) · Cancer · doi:10.1002/1097-0142(19880101)61:1<23::aid-cncr2820610106>3.0.co;2-m · Cited by 417
Self-citationGrier, H. E. (1997) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70541-1 · Cited by 321
Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from the EICESS studies
Paulussen, M., Ahrens, S., Burdach, S., Craft, A., Dockhorn-Dworniczak, B., Dunst, J., Fröhlich, B., Winkelmann, W., Zoubek, A., & Jürgens, H. (1998) · Annals of Oncology · doi:10.1023/a:1008208511815 · Cited by 317
Self-citationJuergens, C., Weston, C., Lewis, I., Whelan, J., Paulussen, M., Oberlin, O., Michon, J., Zoubek, A., Juergens, H., & Craft, A. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20820 · Cited by 282
Self-citationPaulussen, M., Ahrens, S., Craft, A. W., Dunst, J., Fröhlich, B., Jabar, S., Rübe, C., Winkelmann, W., Wissing, S., Zoubek, A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.3044 · Cited by 249
Self-citationCraft, A. W., Cotterill, S. J., Malcolm, A., Spooner, D. A., Grimer, R. J., Souhami, R. L., Imeson, J., & Lewis, I. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3628 · Cited by 226
Self-citationSurvival After Recurrence of Ewing’s Sarcoma Family of Tumors
Barker, L. M., Pendergrass, T. W., Sanders, J. E., & Hawkins, D. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.105 · Cited by 219
Cangir, A., Vietti, T. J., Gehan, E. A., Burgert, E. O., Thomas, P., Tefft, M., Nesbit, M. E., Kissane, J., & Pritchard, D. (1990) · Cancer · doi:10.1002/1097-0142(19900901)66:5<887::aid-cncr2820660513>3.0.co;2-r · Cited by 217
Burdach, S., Jürgens, H., Peters, C., Nürnberger, W., Mauz-Körholz, C., Körholz, D., Paulussen, M., Pape, H., Dilloo, D., & Koscielniak, E. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.8.1482 · Cited by 214
Self-citationSurvival Analysis: A Practical Approach
Machin, D., Cheung, Y. B., & Parmar, M. K. (2006) · Wiley eBooks · doi:10.1002/0470034572 · Cited by 210
Meyers, P. A., Krailo, M. D., Ladanyi, M., Chan, K.-W., Sailer, S. L., Dickman, P. S., Baker, D. L., Davis, J. H., Gerbing, R. B., Grovas, A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2812 · Cited by 206
A multidisciplinary study investigating radiotherapy in Ewing’s sarcoma: end results of POG #8346
Donaldson, S. S., Torrey, M., Link, M. P., Glicksman, A., Gilula, L., Laurie, F., Manning, J., Neff, J., Reinus, W., Thompson, E., et al. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00191-6 · Cited by 205
Klein, J., Rizzo, J., Zhang, M.-J., & Keiding, N. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703271 · Cited by 197
Kolb, E. A., Kushner, B. H., Gorlick, R., Laverdiere, C., Healey, J. H., LaQuaglia, M. P., Huvos, A. G., Qin, J., Vu, H. T., Wexler, L., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.033 · Cited by 180
Evans, R. G., Nesbit, M. E., Gehan, E. A., Garnsey, L. A., Burgert, O., Vietti, T. J., Cangir, A., Tefft, M., Thomas, P., & Askin, F. B. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.7.1173 · Cited by 171
Horowitz, M. E., Kinsella, T. J., Wexler, L. H., Belasco, J., Triche, T., Tsokos, M., Steinberg, S. M., McClure, L., Longo, D. L., & Steis, R. G. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.1911 · Cited by 167
Haeusler, J., Ranft, A., Boelling, T., Gosheger, G., Braun‐Munzinger, G., Vieth, V., Burdach, S., van den Berg, H., Juergens, H., & Dirksen, U. (2010) · Cancer · doi:10.1002/cncr.24740 · Cited by 166
Self-citationKushner, B. H., Meyers, P. A., Gerald, W. L., Healey, J. H., La Quaglia, M. P., Boland, P., Wollner, N., Casper, E. S., Aledo, A., & Heller, G. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.11.2796 · Cited by 163
Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors
Burdach, S. E. G., van Kaick, B., Laws, H. ‐., Ahrens, S., Haase, R., Körholz, D., Pape, H., Dunst, J., Kahn, T., Willers, R., et al. (2000) · Annals of Oncology · doi:10.1023/a:1026539908115 · Cited by 146
Self-citationLadenstein, R. L., Lasset, C., Pinkerton, R., Jm, Z., Peters, C., Burdach, S. E. G., Pardo, N., Dallorso, S., Coze, C., & Dollorso, G. (1995) · PubMed · Cited by 133
Self-citationOberlin, O., Rey, A., Defachelles, A. S., Philip, T. O., Plantaz, D., Schmitt, C., Plouvier, E., Lejars, O., Rubie, H., Terrier, P., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.7059 · Cited by 131
Self-citationMarina, N. M., Pappo, A. S., Parham, D. M., Cain, A. M., Rao, B. N., Poquette, C. A., Pratt, C. B., Greenwald, C. A., & Meyer, W. H. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.180 · Cited by 125
Treatment strategies for metastatic Ewing's sarcoma
Pinkerton, R., Bataillard, A., Guillo, S., Oberlin, O., Fervers, B., & Philip, T. O. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00131-9 · Cited by 89
Self-citationDevelopment of IGF-IR inhibitors in pediatric sarcomas
Kolb, E. A., & Gorlick, R. G. (2009) · Current Oncology Reports · doi:10.1007/s11912-009-0043-1 · Cited by 51
Williams, B. A., Williams, K. M., Doyle, J., Stephens, D., Greenberg, M., Malkin, D. M., & Pappo, A. S. (2004) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200404000-00006 · Cited by 32
Cited by
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Self-citationEwing Sarcoma: Current Management and Future Approaches Through Collaboration
Gaspar, N., Hawkins, D. S., Dirksen, U., Lewis, I. J., Ferrari, S., Le Deley, M.-C., Kovar, H., Grimer, R., Whelan, J., Claude, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5256 · Cited by 722
Self-citationBone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hogendoorn, P. C. W., Athanasou, N., Bielack, S., De Alava, E., Dei Tos, A. P., Ferrari, S., Gelderblom, H., Grimer, R., Sundby Hall, K., Hassan, B., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq223 · Cited by 718
Self-citationTirode, F., Surdez, D., Ma, X., Parker, M., Le Deley, M. C., Bahrami, A., Zhang, Z., Lapouble, E., Grossetête-Lalami, S., Rusch, M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0622 · Cited by 565
Self-citationSnowden, J. A., Sánchez-Ortega, I., Corbacioglu, S., Basak, G. W., Chabannon, C., de la Camara, R., Dolstra, H., Duarte, R. F., Glass, B., Greco, R., et al. (2022) · Bone Marrow Transplantation · doi:10.1038/s41409-022-01691-w · Cited by 379
Metadata
- Authors
- Ladenstein, R., Pötschger, U., Le Deley, M. C., Whelan, J., Paulussen, M., Oberlin, O., van den Berg, H., Dirksen, U., Hjorth, L., Michon, J., Lewis, I., Craft, A., & Jürgens, H.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-07-10
- Volume
- 28
- Issue
- 20
- Pages
- 3284-3291
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2042936828
- Cited by
- 540
- References
- 33
- FWCI
- 19.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.